Medicus Pharma Warrant
MDCXW
6 hedge funds and large institutions have $187K invested in Medicus Pharma Warrant in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$27.2K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$26.5K |
| 3 |
CS
Clear Street
New York
|
+$26.4K |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$17.6K |
| 5 |
CCM
Connective Capital Management
Palo Alto,
California
|
+$3.84K |
Top Sellers
MDCXW Hedge Fund Activity: Q4 2024 in Review
6 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma Warrant (MDCXW) for Q4 2024, worth a combined $187K.
Buyers outnumbered sellers: 6 funds opened new MDCXW positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $27.2K.
- 6 institutional investors held Medicus Pharma Warrant (MDCXW) as of Q4 2024, up from 0 in Q3 2024.
- Funds reported $187K of Medicus Pharma Warrant stock for Q4 2024.
- 6 funds opened new Medicus Pharma Warrant positions in Q4 2024 and 0 closed out, a net change of +6 holders.
- The largest Medicus Pharma Warrant buyer in Q4 2024 was Anson Funds Management, an estimated $27.2K added.
Based on aggregated 13F filings for Q4 2024.